Brief Information of the Cell Line and Protein
Cell Line ID: CL001035 , CHO-mtAEQ
Category Spontaneously immortalized cell line
Organism
Cricetulus griseus (Chinese hamster)
Cellosaurus ID
CVCL_0214
Protein ID: PT01909 , Neuropeptide Y receptor type 4
Gene Name NPY4R
Organism Homo sapiens, Human
Protein Classification Membrane receptor
Uniprot ID P50391
Table of Molecular Bioactivities Related to the Cell Line and Protein
Cell Line ID: CL001035  Protein ID: PT01909
 
Compound ID Compound Name Compound Formula
CP0868331
(9S,12S,15S)-12-((1H-indol-3-yl)methyl)-N-((S)-1-((S)-1-((S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-ylamino)-5-guanidino-1-oxopentan-2-ylamino)-4-methyl-1-oxopentan-2-yl)-15-(3-guanidinopropyl)-4-imino-2,11,14,17,20-pentaoxo-1,3,5,10,13,16,21-heptaazacyclopentacosane-9-carboxamide
   Show/Hide
C53H81N19O10
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0418989
(9S,12S,15S)-4-amino-N-[(2S)-1-[[(2S)-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-15-[3-(diaminomethylideneamino)propyl]-12-[(4-hydroxyphenyl)methyl]-2,11,14,17,20-pentaoxo-1,3,5,10,13,16,21-heptazacyclopentacos-4-ene-9-carboxamide
   Show/Hide
C51H80N18O11
 1
1
EC50 = 2.692 nM
   TI
   LI
   LO
   TS
CP0451146
(4S)-5-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-1-[(2S)-2-[[(2S)-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidine-2-carbonyl]amino]-4-methylpentanoyl]amino]-4-carboxybutanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]-4-oxobutanoyl]amino]propanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoic acid
   Show/Hide
C185H287N53O54S2
 1
1
EC50 = 10.96 nM
   TI
   LI
   LO
   TS
CP0451154
(15S,18S,21S)-2-amino-N-[(2S)-1-[[(2S)-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-15-[3-(diaminomethylideneamino)propyl]-18-[(4-hydroxyphenyl)methyl]-4,10,13,16,19-pentaoxo-1,3,5,9,14,17,20-heptazacyclotetracosene-21-carboxamide
   Show/Hide
C50H78N18O11
 1
1
EC50 = 15.14 nM
   TI
   LI
   LO
   TS
CP0418600
(9S,12S,15S)-4-amino-15-(4-aminobutyl)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-12-[(4-hydroxyphenyl)methyl]-2,11,14,17,20-pentaoxo-1,3,5,10,13,16,21-heptazacyclopentacos-4-ene-9-carboxamide
   Show/Hide
C51H80N16O11
 1
1
EC50 = 25.7 nM
   TI
   LI
   LO
   TS
CP0868314
(13R,16R,19R)-1-amino-13-((R)-1-((R)-1-((R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-ylamino)-5-guanidino-1-oxopentan-2-ylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-ylcarbamoyl)-19-(3-guanidinopropyl)-16-(4-hydroxybenzyl)-8-imino-6,15,18,21-tetraoxo-5,7,9,14,17,20-hexaazatetracosan-24-oic acid
   Show/Hide
C56H81N19O12
 1
1
EC50 = 75.86 nM
   TI
   LI
   LO
   TS
CP0868315
(6S,9S,12S,15S,18S)-9-((1H-indol-3-yl)methyl)-1-amino-6-((S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-ylcarbamoyl)-12-(3-(3-(3-aminopropylcarbamoyl)guanidino)propyl)-18-(3-guanidinopropyl)-15-(4-hydroxybenzyl)-1-imino-8,11,14,17,20-pentaoxo-2,7,10,13,16,19-hexaazatricosan-23-oic acid
   Show/Hide
C55H79N19O12
 1
1
EC50 = 91.2 nM
   TI
   LI
   LO
   TS
CP0943063
(13S,16S,19S)-16-((1H-indol-3-yl)methyl)-1-amino-13-((S)-1-((S)-1-((S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-ylamino)-5-guanidino-1-oxopentan-2-ylamino)-4-methyl-1-oxopentan-2-ylcarbamoyl)-19-(3-guanidinopropyl)-8-imino-6,15,18,21-tetraoxo-5,7,9,14,17,20-hexaazatetracosan-24-oic acid
   Show/Hide
C53H83N19O11
 1
1
EC50 = 104.71 nM
   TI
   LI
   LO
   TS
CP0418614
4-[[(2S)-1-[[(2S)-1-[[(2S)-5-[[amino-(3-aminopropylcarbamoylamino)methylidene]amino]-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid
   Show/Hide
C50H80N18O12
 1
1
EC50 = 177.83 nM
   TI
   LI
   LO
   TS
CP0479645
(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-N-[(2S)-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-4-methylpentanamide
   Show/Hide
C44H70N16O9
 2
1
EC50 = 181.97 nM
   TI
   LI
   LO
   TS
2
Ki = 3.388 nM
   TI
   LI
   LO
   TS
CP0902753
(9S,12S,15S)-N-((S)-1-((S)-1-((S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-ylamino)-5-guanidino-1-oxopentan-2-ylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)-15-(3-guanidinopropyl)-12-(4-hydroxybenzyl)-4-imino-2,11,14,17,20-pentaoxo-1,3,5,10,13,16,21-heptaazacyclopentacosane-9-carboxamide
   Show/Hide
C56H79N19O11
 1
1
EC50 = 190.55 nM
   TI
   LI
   LO
   TS
CP0418602
4-[[(2S)-1-[[(2S)-1-[[(2S)-5-[[amino-(4-aminobutylcarbamoylamino)methylidene]amino]-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid
   Show/Hide
C51H82N18O12
 1
1
EC50 = 204.17 nM
   TI
   LI
   LO
   TS
CP0451149
(9S,12S)-4-amino-N-[(2S)-1-[[(2S)-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-12-[3-(diaminomethylideneamino)propyl]-2,11,14,17-tetraoxo-1,3,5,10,13,18-hexazacyclodocos-4-ene-9-carboxamide
   Show/Hide
C42H71N17O9
 1
1
EC50 = 363.08 nM
   TI
   LI
   LO
   TS
CP0868316
(15S,18S,21S)-N-((S)-1-((S)-1-((S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-ylamino)-5-guanidino-1-oxopentan-2-ylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)-15-(3-guanidinopropyl)-18-(4-hydroxybenzyl)-2-imino-4,10,13,16,19-pentaoxo-1,3,5,9,14,17,20-heptaazacyclotetracosane-21-carboxamide
   Show/Hide
C55H77N19O11
 1
1
EC50 = 380.19 nM
   TI
   LI
   LO
   TS
CP0451153
(2S,8S,11S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-2-[3-(diaminomethylideneamino)propyl]-8-[(4-hydroxyphenyl)methyl]-3,6,9,14-tetraoxo-1,4,7,10-tetrazacyclotetradecane-11-carboxamide
   Show/Hide
C49H76N18O11
 1
1
EC50 = 676.08 nM
   TI
   LI
   LO
   TS
CP0418613
(15S,18S,21S,24S,27S)-2-amino-N-[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-15,21-bis[3-(diaminomethylideneamino)propyl]-18-[(4-hydroxyphenyl)methyl]-24-(2-methylpropyl)-4,10,13,16,19,22,25-heptaoxo-1,3,5,9,14,17,20,23,26-nonazacyclotriacontene-27-carboxamide
   Show/Hide
C50H78N18O11
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0451151
4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-[[amino-(3-aminopropylcarbamoylamino)methylidene]amino]-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid
   Show/Hide
C50H80N18O12
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0451152
(5R,8S,11S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-5,8-bis[3-(diaminomethylideneamino)propyl]-3,6,9,14-tetraoxo-1,4,7,10-tetrazacyclotetradecane-11-carboxamide
   Show/Hide
C40H67N17O9
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0531386
(5R,8S,11S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-5,8-bis[3-(diaminomethylideneamino)propyl]-3,6,9,13-tetraoxo-1,4,7,10-tetrazacyclotridecane-11-carboxamide
   Show/Hide
C39H65N17O9
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS